Abliva AB Ownership

ABLI Stock  SEK 0.43  0.01  2.38%   
Abliva AB holds a total of 1.06 Billion outstanding shares. 30% of Abliva AB outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abliva AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Abliva Stock Ownership Analysis

About 49.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.97. Some equities with similar Price to Book (P/B) outperform the market in the long run. Abliva AB recorded a loss per share of 0.31. The entity had not issued any dividends in recent years. Abliva AB , a pharmaceutical company, engages in the research and development of mitochondrial medicine. Abliva AB was incorporated in 2000 and is headquartered in Lund, Sweden. Abliva AB is traded on Stockholm Stock Exchange in Sweden. For more info on Abliva AB please contact Catharina Johansson at 46 4 62 75 62 20 or go to https://abliva.com.

Abliva AB Outstanding Bonds

Abliva AB issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Abliva AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Abliva bonds can be classified according to their maturity, which is the date when Abliva AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Abliva Stock Analysis

When running Abliva AB's price analysis, check to measure Abliva AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abliva AB is operating at the current time. Most of Abliva AB's value examination focuses on studying past and present price action to predict the probability of Abliva AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abliva AB's price. Additionally, you may evaluate how the addition of Abliva AB to your portfolios can decrease your overall portfolio volatility.